The flow cytometric VASP assay can be used to determine the effectiveness of clopidogrel in patients treated with abciximab.
van Werkum
J W
JW
van der Stelt
C A K
CA
Seesing
T H
TH
ten Berg
J M
JM
Hackeng
C M
CM
D000077284:Abciximab; D000787:Angina Pectoris / Q000097:blood* / Q000188:drug therapy; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000925:Anticoagulants / Q000737:chemistry; D015815:Cell Adhesion Molecules / Q000737:chemistry / Q000276:immunology; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry / Q000379:methods*; D006403:Hematologic Tests / Q000379:methods*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology*; D051379:Mice; D008840:Microfilament Proteins / Q000737:chemistry / Q000276:immunology; D010750:Phosphoproteins / Q000737:chemistry / Q000276:immunology; D010979:Platelet Function Tests / Q000379:methods*; D012044:Regression Analysis; D015203:Reproducibility of Results; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000098662:Vasodilator-Stimulated Phosphoprotein
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D015815:Cell Adhesion Molecules; D007140:Immunoglobulin Fab Fragments; D008840:Microfilament Proteins; D010750:Phosphoproteins; D000098662:Vasodilator-Stimulated Phosphoprotein; D000077144:Clopidogrel; D013988:Ticlopidine; D000077284:Abciximab